Paula Munderi

3.6k total citations
95 papers, 2.0k citations indexed

About

Paula Munderi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Paula Munderi has authored 95 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 42 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Paula Munderi's work include HIV/AIDS Research and Interventions (59 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (39 papers). Paula Munderi is often cited by papers focused on HIV/AIDS Research and Interventions (59 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (39 papers). Paula Munderi collaborates with scholars based in Uganda, United Kingdom and Zimbabwe. Paula Munderi's co-authors include Heiner Grosskurth, Charles F. Gilks, Diana M. Gibb, Lynne Mofenson, Peter Mugyenyi, Cissy Kityo, A. Sarah Walker, James Hakim, Andrew Reid and Francis Ssali and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Paula Munderi

90 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Munderi Uganda 24 1.4k 655 611 512 212 95 2.0k
Ferdinand W N M Wit Netherlands 22 1.4k 1.0× 550 0.8× 910 1.5× 325 0.6× 144 0.7× 43 2.1k
Alana T. Brennan United States 27 1.7k 1.2× 833 1.3× 640 1.0× 439 0.9× 289 1.4× 81 2.2k
Susan L. Rosenkranz United States 21 993 0.7× 258 0.4× 684 1.1× 437 0.9× 207 1.0× 52 1.9k
Gabriel Chamie United States 27 1.5k 1.1× 976 1.5× 301 0.5× 230 0.4× 215 1.0× 112 2.1k
Dalsone Kwarisiima United States 25 1.3k 0.9× 772 1.2× 289 0.5× 219 0.4× 210 1.0× 64 1.7k
Winnie Muyindike Uganda 26 1.7k 1.2× 1.1k 1.7× 495 0.8× 378 0.7× 301 1.4× 124 2.3k
Adeodata Kekitiinwa Uganda 24 1.0k 0.7× 390 0.6× 489 0.8× 272 0.5× 309 1.5× 77 1.6k
Daniela Garone South Africa 20 1.1k 0.8× 488 0.7× 503 0.8× 280 0.5× 96 0.5× 53 1.4k
Frank van Leth Netherlands 27 2.1k 1.4× 1.0k 1.6× 817 1.3× 760 1.5× 167 0.8× 107 2.7k
Alemayehu Amberbir United Kingdom 25 1.0k 0.7× 542 0.8× 195 0.3× 244 0.5× 290 1.4× 68 2.3k

Countries citing papers authored by Paula Munderi

Since Specialization
Citations

This map shows the geographic impact of Paula Munderi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Munderi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Munderi more than expected).

Fields of papers citing papers by Paula Munderi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Munderi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Munderi. The network helps show where Paula Munderi may publish in the future.

Co-authorship network of co-authors of Paula Munderi

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Munderi. A scholar is included among the top collaborators of Paula Munderi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Munderi. Paula Munderi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Munderi, Paula, et al.. (2019). Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV. Southern African Journal of HIV Medicine. 20(1). 949–949. 3 indexed citations
3.
Kasirye, Ronnie, Heiner Grosskurth, Paula Munderi, et al.. (2016). Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study. Malaria Journal. 15(1). 361–361. 3 indexed citations
4.
Namakoola, Ivan, Billy N. Mayanja, Joseph Lutaakome, et al.. (2016). From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults. BMC Research Notes. 9(1). 515–515. 11 indexed citations
5.
Crook, Angela M., Anna Turkova, Victor Musiime, et al.. (2016). Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Medicine. 14(1). 50–50. 34 indexed citations
6.
Nunn, Andrew, Zacchaeus Anywaine, Janet Seeley, et al.. (2016). Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda. Contemporary Clinical Trials Communications. 3. 142–146. 4 indexed citations
7.
Bwakura‐Dangarembizi, Mutsa, Lindsay Kendall, Sabrina Bakeera–Kitaka, et al.. (2014). A Randomized Trial of Prolonged Co-trimoxazole in HIV-Infected Children in Africa. New England Journal of Medicine. 370(1). 41–53. 76 indexed citations
8.
Revill, Paul, Simon Walker, Kusum Nathoo, et al.. (2014). Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS. 29(2). 201–210. 5 indexed citations
9.
Musiime, Victor, Adrian Cook, Sabrina Bakeera–Kitaka, et al.. (2013). Bacteremia, Causative Agents and Antimicrobial Susceptibility Among HIV-1–infected Children on Antiretroviral Therapy in Uganda and Zimbabwe. The Pediatric Infectious Disease Journal. 32(8). 856–862. 21 indexed citations
10.
Gibb, Diana M., E. C. Russell, Ennie Chidziva, et al.. (2012). Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial. PLoS Medicine. 9(5). e1001217–e1001217. 111 indexed citations
11.
Lara, A. Medina, Jesse Kigozi, Jovita Amurwon, et al.. (2012). Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe. PLoS ONE. 7(4). e33672–e33672. 22 indexed citations
12.
Munderi, Paula, A Sarah Walker, Cissy Kityo, et al.. (2011). Is HLA-B*5701 associated with clinically diagnosed hypersensitivity to abacavir in Ugandan HIV-infected adults?. Tropical Medicine & International Health. 16(2). 200–204. 13 indexed citations
13.
Miiro, George, Susan Nakubulwa, Christine Watera, et al.. (2010). Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/μl among HIV-1-infected Ugandan adults. Tropical Medicine & International Health. 15(4). 396–404. 9 indexed citations
14.
Munderi, Paula, Wendy Snowden, A. Sarah Walker, et al.. (2010). Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART. Tropical Medicine & International Health. 16(2). 200–204. 17 indexed citations
15.
Munderi, Paula. (2009). When to start antiretroviral therapy in adults in low- and middle-income countries: science and practice. Current Opinion in HIV and AIDS. 5(1). 6–11. 5 indexed citations
16.
Lara, A. Medina, B. Nyanzi Wakholi, Paula Munderi, et al.. (2008). Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS. 22(Suppl 1). S123–S130. 24 indexed citations
17.
Kikaire, Bernard, Saye Khoo, A. Sarah Walker, et al.. (2007). Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy. AIDS. 21(6). 733–737. 19 indexed citations
18.
Munderi, Paula, et al.. (2005). Prescription for healthy development : increasing access to medicines. 31 indexed citations
19.
Lee, Kwan Ho, et al.. (2005). Clinical and Bronchoscopic Findings in Ugandans with Pulmonary Kaposi's Sarcoma. The Korean Journal of Internal Medicine. 20(4). 290–290. 16 indexed citations
20.
Mofenson, Lynne & Paula Munderi. (2002). Safety of Antiretroviral Prophylaxis of Perinatal Transmission for HIV-Infected Pregnant Women and Their Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(2). 200–215. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdinand W N M Wit Breakdown of academic impact, for papers by Alana T. Brennan Breakdown of academic impact, for papers by Susan L. Rosenkranz Breakdown of academic impact, for papers by Gabriel Chamie Breakdown of academic impact, for papers by Dalsone Kwarisiima Breakdown of academic impact, for papers by Winnie Muyindike Breakdown of academic impact, for papers by Adeodata Kekitiinwa Breakdown of academic impact, for papers by Daniela Garone Breakdown of academic impact, for papers by Frank van Leth Breakdown of academic impact, for papers by Alemayehu Amberbir
Rankless by CCL
2026